BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12777743)

  • 1. Conversion technology and cancer predispositions.
    Papadopoulos N
    Methods Mol Biol; 2003; 223():415-23. PubMed ID: 12777743
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion technology and its role in genetic testing of inherited diseases.
    Papadopoulos N
    Expert Rev Mol Diagn; 2003 Jul; 3(4):497-506. PubMed ID: 12877388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
    Domchek SM; Bradbury A; Garber JE; Offit K; Robson ME
    J Clin Oncol; 2013 Apr; 31(10):1267-70. PubMed ID: 23460708
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic testing for familial cancer. The French National Report (year 2003).
    Eisinger F
    Community Genet; 2008; 11(1):63-7. PubMed ID: 18196919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
    Li J; Makrigiorgos GM
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):427-32. PubMed ID: 19290875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epialleles and common disease.
    Peedicayil J
    Med Hypotheses; 2005; 64(1):215. PubMed ID: 15533644
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer risk assessment and cancer prevention: promises and challenges.
    Reid BJ
    Cancer Prev Res (Phila); 2008 Sep; 1(4):229-32. PubMed ID: 19138965
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
    Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
    Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary cancer predisposition syndromes.
    Garber JE; Offit K
    J Clin Oncol; 2005 Jan; 23(2):276-92. PubMed ID: 15637391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
    Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
    Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting patients through genetic screening for cancer risk.
    Sadler GR; Wasserman L; Fullerton JT; Romero M
    Medsurg Nurs; 2004 Aug; 13(4):233-46. PubMed ID: 15384477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal selection of individuals for BRCA mutation testing.
    Evans DG; Lalloo F; Eccles D
    J Clin Oncol; 2006 Jul; 24(20):3311; author reply 3311-2. PubMed ID: 16829657
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparities in genetic testing: thinking outside the BRCA box.
    Hall MJ; Olopade OI
    J Clin Oncol; 2006 May; 24(14):2197-203. PubMed ID: 16682739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cancer clip.
    Redmond J;
    J Ky Med Assoc; 2005 Apr; 103(4):168. PubMed ID: 15853185
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical genotyping: the need for interrogation of single nucleotide polymorphisms and mutations in the clinical laboratory.
    Tsongalis GJ; Coleman WB
    Clin Chim Acta; 2006 Jan; 363(1-2):127-37. PubMed ID: 16102741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of haploidy and diploidy.
    Otto SP; Gerstein AC
    Curr Biol; 2008 Dec; 18(24):R1121-4. PubMed ID: 19108763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.